Home NDC 70748-387 PITOLISANT
Product NDC 70748-387
11-digit product format 707480387
Labeler code 70748
Product ID 70748-387_e46eef01-594a-49ca-a453-0b680e4ee730
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name pitolisant
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Lupin Pharmaceuticals, Inc.
Application ANDA218846
Marketing category ANDA
Marketing start 2026-10-16
Substance PITOLISANT HYDROCHLORIDE
Active strength 17.8 mg/1
Pharmacologic classes Cytochrome P450 3A4 Inducers [MoA], Histamine H3 Receptor Antagonists [MoA], Histamine H3 Receptor Inverse Agonists [MoA], Histamine-3 Receptor Antagonist/Inverse Agonist [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A218846-001 PITOLISANT HYDROCHLORIDE PITOLISANT HYDROCHLORIDE EQ 4.45MG BASE TABLET / ORAL AB 2026-08-14 A218846-002 PITOLISANT HYDROCHLORIDE PITOLISANT HYDROCHLORIDE EQ 17.8MG BASE TABLET / ORAL AB 2026-08-14
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A218846-001 PITOLISANT HYDROCHLORIDE EQ 4.45MG BASE TABLET / ORAL AB 2026-08-14 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A218846-002 PITOLISANT HYDROCHLORIDE EQ 17.8MG BASE TABLET / ORAL AB 2026-08-14 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A218846-001 PITOLISANT HYDROCHLORIDE EQ 4.45MG BASE TABLET / ORAL AB 2026-08-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 A218846-002 PITOLISANT HYDROCHLORIDE EQ 17.8MG BASE TABLET / ORAL AB 2026-08-14 c2088c7a36db…2026-09-14 22:38:34 2026-08 A218846-001 PITOLISANT HYDROCHLORIDE EQ 4.45MG BASE TABLET / ORAL AB 2026-08-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 A218846-002 PITOLISANT HYDROCHLORIDE EQ 17.8MG BASE TABLET / ORAL AB 2026-08-14 84e616aacf4f…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base PITOLISANT
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength PITOLISANT HYDROCHLORIDE 17.8 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination YV33CH63HI Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2197884 Internal RxNorm lookup 2197892 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 70748-387-01 70748038701 1 BOTTLE in 1 CARTON (70748-387-01) / 30 TABLET, FILM COATED in 1 BOTTLE 1 bottle 2026-10-16 No No Current